A claims analysis found different responses to opioid policies across groups, but its benzodiazepine-overlap findings were narrower than its dose findings.
The investigators examined first opioid fills in opioid-naive adults with chronic pain during 2014–2018. Higher-dose initial fills declined differently by provider, geography, and insurance after historical guidance and coverage changes. The study did not find corresponding between-group differences in the rate of initial opioid fills overlapping benzodiazepines.
The design establishes temporal associations rather than isolated policy effects. Filled prescriptions are not all written prescriptions or observed consumption. Results concern a particular historical population and should not be treated as a description of current prescribing rules.
For a combined-drug review, distinguish an overlapping supply record from concurrent administration. A policy’s association with lower opioid doses does not prove that co-exposure changed in the same way. Case-specific fill dates, quantities, actual use, and clinical decisions remain necessary.
Source reviewed: Association of opioid fills with centers for disease control and prevention opioid guidelines and pa (PMC8636786). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Endometriosis Claims Study Described Opioid Escalation and Sedative Co-Prescribing; Bronchiolitis Withdrawal Model Found an Opioid Association but No Clear Benzodiazepine Association.